Assessment of efficacy and safety of mRNA COVID-19 vaccines in children aged 5 to 11 years: a systematic review and meta-analysis

A Watanabe, R Kani, M Iwagami, H Takagi… - JAMA …, 2023 - jamanetwork.com
Importance Evidence of the efficacy and safety of messenger RNA (mRNA) COVID-19
vaccines in children aged 5 to 11 years has been emerging. Collecting these data will inform …

Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review

C Duan, L Liu, T Wang, G Wang, Z Jiang, H Li, G Zhang… - BMC medicine, 2024 - Springer
Background Experiences during childhood and adolescence have enduring impacts on
physical and mental well-being, overall quality of life, and socioeconomic status throughout …

[HTML][HTML] SARS-CoV-2 vaccines and myocarditis

AK Sularz, A Hua, T Ismail - Clinical Medicine, 2023 - ncbi.nlm.nih.gov
The development of safe and effective vaccines against severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2) was a major turning point in the fight against the Coronavirus …

Exploring Factors Influencing Changes in Incidence and Severity of Multisystem Inflammatory Syndrome in Children

P Castaldo, G d'Alanno, GB Biserni, M Moratti, F Conti… - Pathogens, 2023 - mdpi.com
Multisystem inflammatory syndrome (MIS-C) is a rare condition associated with COVID-19
affecting children, characterized by severe and aberrant systemic inflammation leading to …

Incidence of myopericarditis after mRNA COVID-19 vaccination: A meta-analysis with focus on adolescents aged 12–17 years

BQ Guo, HB Li, LQ Yang - Vaccine, 2023 - Elsevier
Background The incidence of myopericarditis after mRNA COVID-19 vaccination among
adolescents aged 12–17 years remains unknown. Therefore, we conducted a study to pool …

Cardiac function evaluation after SARS-CoV-2 mRNA vaccination in children and adolescents: a prospective speckle-tracking echocardiography study

J Sabatino, C Di Chiara, D Lauretta, J Fumanelli… - Vaccines, 2023 - mdpi.com
Background: Possible cardiac impairment after SARS-CoV-2 mRNA vaccination is a
common driver of parental vaccine hesitancy. We performed a comprehensive …

[HTML][HTML] Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases

PBT Saputra, RB Kurniawan, D Trilistyoati… - Biomolecules and …, 2023 - ncbi.nlm.nih.gov
Vaccination is significant to control, mitigate, and recover from the destructive effects of
coronavirus disease 2019 (COVID-19). The incidence of myocarditis following COVID-19 …

Overview of SARS-CoV-2 infection and vaccine associated myocarditis compared to non-COVID-19-associated myocarditis: A systematic review and meta-analysis

Y Ishisaka, A Watanabe, T Aikawa, K Kanaoka… - International Journal of …, 2023 - Elsevier
Background Previous literature suggests that both SARS-CoV-2 infection and COVID-19
mRNA vaccine are associated with myocarditis, in which the incidence is higher in the …

Myocarditis or pericarditis events after BNT162b2 vaccination in individuals aged 12 to 17 years in Ontario, Canada

SA Buchan, S Alley, CY Seo, C Johnson… - JAMA …, 2023 - jamanetwork.com
Importance The risk of myocarditis or pericarditis after COVID-19 messenger RNA vaccines
varies by age and sex, and there is some evidence to suggest increasing risk with shorter …

Protocol of a scoping review of systematic reviews and meta-analyses about COVID-19 vaccines and associated adverse events from vaccination

SM Pranić, LT Vasanthan, JY Thompson, V Mishra… - Plos one, 2023 - journals.plos.org
The continuous dissemination of coronavirus disease of 2019 (COVID-19) literature can
inform decision-makers and the public. Since the widespread use of COVID-19 vaccines …